Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics.

Psychopharmacology
Xiang Yang ZhangThomas R Kosten

Abstract

Schizophrenia is associated with various abnormalities in the immune system. Suppression of inflammatory cytokines by cigarette smoke is well-established. The purpose of this study was to determine any differences in cytokine profiles in smokers and nonsmokers with schizophrenia and whether there were any relationships among altered cytokine profiles and psychopathological symptoms. Serum interleukin (IL)-2, IL-6, IL-8, and tumor necrosis factor (TNF)-alpha levels were measured in 96 male inpatients with DSM-IV schizophrenia: 66 smokers and 30 nonsmokers. Symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS). The positive PANSS symptoms were lower in smokers than nonsmokers, while the negative symptoms were lower in those who smoked more cigarettes. Cytokine levels were positively correlated: IL-2 level with IL-6 and IL-6 with both IL-8 and TNF-alpha. Both IL-2 and IL-6, but not IL-8 or TNF-alpha, were significantly lower in smokers than nonsmokers (p < 0.002; p < 0.01). Lower IL-2 levels correlated with fewer negative symptoms and with smoking more cigarettes. The fewer positive symptoms in smokers and fewer negative symptoms in those who smoked more cigarettes may be associated with nicotine-induced sup...Continue Reading

References

Dec 1, 1992·Schizophrenia Research·J B Lohr, K Flynn
Sep 1, 1992·The American Journal of Psychiatry·D C GoffE Amico
Dec 1, 1994·Schizophrenia Research·A E HennebergS Ruffert
Feb 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·H M XuG P Hemmings
Jan 1, 1993·Acta Psychiatrica Scandinavica·N MüllerR Eckstein
Sep 1, 1993·The American Journal of Psychiatry·J LicinioJ H Krystal
Dec 1, 1993·The American Journal of Psychiatry·L E AdlerR Freedman
May 1, 1996·Schizophrenia Research·I BakerR J Wyatt
Jan 21, 1997·Proceedings of the National Academy of Sciences of the United States of America·R FreedmanW Byerley
Nov 1, 1994·Harvard Review of Psychiatry·R FreedmanC Miller
Jan 1, 1997·European Archives of Psychiatry and Clinical Neuroscience·N MüllerM Ackenheil
Jun 4, 1998·Journal of Neuroimmunology·M L Sopori, W Kozak
Jun 5, 1998·Schizophrenia Bulletin·L E AdlerR Freedman
Nov 13, 1998·The American Journal of Psychiatry·G W DalackJ H Meador-Woodruff
Feb 2, 2000·European Archives of Psychiatry and Clinical Neuroscience·N MüllerM J Schwarz
Apr 28, 2000·The American Journal of Psychiatry·Z Kronfol, D G Remick
Jun 24, 2000·Proceedings of the Society for Experimental Biology and Medicine·N HallquistS Pross
Aug 10, 2000·The Journal of Allergy and Clinical Immunology·Y OuyangB M Freed
Mar 30, 2001·Schizophrenia Research·C L CazzulloM Clerici
Jan 23, 2002·Molecular Psychiatry·N Weidner, M H Tuszynski
May 30, 2002·Nature Reviews. Immunology·Mohan Sopori
Sep 13, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert C SmithAngelica Kloos
Oct 3, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Robin G McCreadie, UNKNOWN Scottish Comorbidity Study Group
Oct 5, 2002·The Journal of Clinical Psychiatry·Jose de LeonFrancisco J Diaz
Feb 20, 2003·Schizophrenia Research·Adrián LLerenaJose de Leon
Feb 16, 2005·International Immunopharmacology·Yukimitsu MamataHerman Friedman
May 12, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xiang Yang ZhangYu Cun Shen
Jun 21, 2005·Neuroscience and Biobehavioral Reviews·Veena Kumari, Peggy Postma
Jul 29, 2006·FEMS Immunology and Medical Microbiology·Herman FriedmanThomas W Klein
Jan 1, 1993·Mediators of Inflammation·C CarusoM A Modica

❮ Previous
Next ❯

Citations

Sep 28, 2013·Schizophrenia Bulletin·Brian Kirkpatrick, Brian J Miller
Jun 7, 2011·Biological Psychiatry·Brian J MillerBrian Kirkpatrick
Mar 29, 2016·Neuroscience Bulletin·Hui-Mei AnXiang-Yang Zhang
Jun 24, 2010·Brain Research·Montserrat VictorianoDominique Hermier
Jun 21, 2015·Neuroscience and Biobehavioral Reviews·Juan C LezaMiguel Bernardo
Nov 6, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kyoung-Sae NaYong-Ku Kim
Jan 31, 2013·Journal of Psychiatric Research·Cristiano NotoElisa Brietzke
Apr 16, 2009·The International Journal of Neuropsychopharmacology·Catherine Bresee, Mark H Rapaport
Sep 24, 2016·Nordic Journal of Psychiatry·Jari-Pekka KlemettiläEsa Leinonen
Jul 18, 2018·The International Journal of Neuropsychopharmacology·Bruno RomeoAmine Benyamina
Jul 3, 2021·Journal of Clinical Medicine·Piotr MarcinowiczAgata Szulc

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here